Brief: ADC Therapeutics Says Co & Certain Of Its Subsidiaries Entered Into First Amendment To Loan Agreement & Guaranty, Dated Aug 15, 2022
Jan 19 (Reuters) - ADC Therapeutics SA ADCT.N :
* ADC THERAPEUTICS SA: ON JAN 16, 2024 CO & CERTAIN OF ITS
SUBSIDIARIES ENTERED INTO FIRST AMENDMENT TO LOAN AGREEMENT &
GUARANTY, DATED AUG 15, 2022
* ADC THERAPEUTICS:AMENDMENT PROVIDES OUT-LICENSING
ARRANGEMENTS
FOR PRECLINICAL COMPOUNDS,CERTAIN TECHNOLOGIES THAT PROVIDE CASH
PROCEEDS ABOVE $75MLN
* ADC THERAPEUTICS: ON JAN 16, LENDERS TO CREDIT DEAL WAIVED
POTENTIAL NON-FINANCIAL EVENTS OF DEFAULT THAT WERE ALLEGED TO
HAVE OCCURRED THEREUNDER
Further company coverage: ADCT.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on ADC Therapeutics SA
See all newsADC Therapeutics plunges after patient deaths in blood cancer drug trial
ADC Therapeutics falls on higher rates of serious side-effects in cancer trial
Switzerland's ADC Therapeutics beats Q1 revenue estimates
Switzerland's ADC Therapeutics posts smaller‑than‑expected Q4 net loss on lower R&D spend
Brief: ADC Therapeutics Q4 Income From Operations USD -17.919 Million Vs. IBES Estimate USD -30.1 Million